Cargando…

SARS-CoV-2 Delta–Omicron Recombinant Viruses, United States

To detect new and changing SARS-CoV-2 variants, we investigated candidate Delta–Omicron recombinant genomes from Centers for Disease Control and Prevention national genomic surveillance. Laboratory and bioinformatic investigations identified and validated 9 genetically related SARS-CoV-2 viruses wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lacek, Kristine A., Rambo-Martin, Benjamin L., Batra, Dhwani, Zheng, Xiao-yu, Hassell, Norman, Sakaguchi, Hitoshi, Peacock, Thomas, Groves, Natalie, Keller, Matthew, Wilson, Malania M., Sheth, Mili, Davis, Morgan L., Borroughs, Mark, Gerhart, Jonathan, Shepard, Samuel S., Cook, Peter W., Lee, Justin, Wentworth, David E., Barnes, John R., Kondor, Rebecca, Paden, Clinton R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Dispatch
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239886/ https://www.ncbi.nlm.nih.gov/pubmed/35551714 http://dx.doi.org/10.3201/eid2807.220526

Ejemplares similares

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages — United States, January 2022–May 2023
por: Ma, Kevin C., et al.
Publicado: (2023)

Serial Intervals and Incubation Periods of SARS-CoV-2 Omicron and Delta Variants, Singapore
por: Zeng, Kangwei, et al.
Publicado: (2023)

Rapid Replacement of SARS-CoV-2 Variants by Delta and Subsequent Arrival of Omicron, Uganda, 2021
por: Bbosa, Nicholas, et al.
Publicado: (2022)

Experimental Infection and Transmission of SARS-CoV-2 Delta and Omicron Variants among Beagle Dogs
por: Lyoo, Kwang-Soo, et al.
Publicado: (2023)

Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022
por: Lambrou, Anastasia S., et al.
Publicado: (2022)

Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19–December 31, 2021
por: Kremer, Cécile, et al.
Publicado: (2022)

Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2
por: Paden, Clinton R., et al.
Publicado: (2020)

Cluster of Oseltamivir-Resistant and Hemagglutinin Antigenically Drifted Influenza A(H1N1)pdm09 Viruses, Texas, USA, January 2020
por: Mohan, Teena, et al.
Publicado: (2021)

Eighth Major Clade for Hepatitis Delta Virus
por: Le Gal, Frédéric, et al.
Publicado: (2006)

Human Cutaneous Anthrax, Georgia 2010–2012
por: Kracalik, Ian, et al.
Publicado: (2014)

Human Lymphadenopathy Caused by Ratborne Bartonella, Tbilisi, Georgia
por: Kandelaki, George, et al.
Publicado: (2016)

Drug-Resistance Mechanisms in Vibrio cholerae O1 Outbreak Strain, Haiti, 2010
por: Sjölund-Karlsson, Maria, et al.
Publicado: (2011)

Cutaneous Leishmaniasis Caused by an Unknown Leishmania Strain, Arizona, USA
por: de Almeida, Marcos, et al.
Publicado: (2021)

Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees
por: Takahashi, Kenichiro, et al.
Publicado: (2022)

Family Cluster of Middle East Respiratory Syndrome Coronavirus Infections, Tunisia, 2013
por: Abroug, Fekri, et al.
Publicado: (2014)

SARS-CoV-2 Incubation Period during the Omicron BA.5–Dominant Period in Japan
por: Ogata, Tsuyoshi, et al.
Publicado: (2023)

High Prevalence of SARS-CoV-2 Omicron Infection Despite High Seroprevalence, Sweden, 2022
por: Groenheit, Ramona, et al.
Publicado: (2023)

Emergence of SARS-CoV-2 Delta Variant, Benin, May–July 2021
por: Yadouleton, Anges, et al.
Publicado: (2022)

Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers
por: Ellingson, Katherine D., et al.
Publicado: (2023)

Emergence and Persistent Dominance of SARS-CoV-2 Omicron BA.2.3.7 Variant, Taiwan
por: Shao, Pei-Lan, et al.
Publicado: (2023)

Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January–March 2022
por: Mefsin, Yonatan M., et al.
Publicado: (2022)

Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain
por: Del Águila-Mejía, Javier, et al.
Publicado: (2022)

Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021–September 2022
por: Foulkes, Sarah, et al.
Publicado: (2023)

Mice Susceptible to SARS Coronavirus
por: Wentworth, David E., et al.
Publicado: (2004)

Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022
por: Kislaya, Irina, et al.
Publicado: (2023)

Serial Interval and Transmission Dynamics during SARS-CoV-2 Delta Variant Predominance, South Korea
por: Ryu, Sukhyun, et al.
Publicado: (2022)

SARS-CoV-2 Seroprevalence before Delta Variant Surge, Chattogram, Bangladesh, March–June 2021
por: Bhuiyan, Taufiqur Rahman, et al.
Publicado: (2022)

Epidemiologic and Genomic Analysis of SARS-CoV-2 Delta Variant Superspreading Event in Nightclub, the Netherlands, June 2021
por: Koopsen, Jelle, et al.
Publicado: (2022)

Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021
por: Vauhkonen, Hanna, et al.
Publicado: (2022)

Spatiotemporal Evolution of SARS-CoV-2 Alpha and Delta Variants during Large Nationwide Outbreak of COVID-19, Vietnam, 2021
por: Tam, Nguyen Thi, et al.
Publicado: (2023)

Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021
por: Glatman-Freedman, Aharona, et al.
Publicado: (2021)

Draft Genome Sequence of French Guiana Leishmania (Viannia) guyanensis Strain 204-365, Assembled Using Long Reads
por: Batra, Dhwani, et al.
Publicado: (2018)

Mammalian Pathogenesis and Transmission of Avian Influenza A(H7N9) Viruses, Tennessee, USA, 2017
por: Belser, Jessica A., et al.
Publicado: (2018)

Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022
por: Kim, Sara S., et al.
Publicado: (2022)

Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants — United States, November 2021–January 2023
por: Scobie, Heather M., et al.
Publicado: (2023)

Equine Influenza A(H3N8) Virus Isolated from Bactrian Camel, Mongolia
por: Yondon, Myagmarsukh, et al.
Publicado: (2014)

Universal Human Papillomavirus Typing Assay: Whole-Genome Sequencing following Target Enrichment
por: Li, Tengguo, et al.
Publicado: (2017)

Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir
por: Mishin, Vasiliy P., et al.
Publicado: (2019)

Antimicrobial Postexposure Prophylaxis for Anthrax: Adverse Events and Adherence
por: Shepard, Colin W., et al.
Publicado: (2002)

Antiviral Drug–Resistant Influenza B Viruses Carrying H134N Substitution in Neuraminidase, Laos, February 2016
por: Baranovich, Tatiana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m25dkrjcjvcr3rflij23f1rdqe